{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:21:10Z","timestamp":1761294070481,"version":"3.40.3"},"publisher-location":"Cham","reference-count":55,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030357269"},{"type":"electronic","value":"9783030357276"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-35727-6_2","type":"book-chapter","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T16:07:08Z","timestamp":1581005228000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans"],"prefix":"10.1007","author":[{"given":"Ryuji","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"March","key":"2_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1126\/science.1204040","volume":"331","author":"MR Stratton","year":"2011","unstructured":"Stratton MR (2011) Exploring the genomes of cancer cells: progress and promise. Science 331(March):1553\u20131558. https:\/\/doi.org\/10.1126\/science.1204040","journal-title":"Science"},{"key":"2_CR2","doi-asserted-by":"publisher","unstructured":"Marcus A, Gowen BG, Thompson TW et al (2014) Recognition of tumors by innate immune system and natural killer cells. Adv Immunol 122:91\u2013128 https:\/\/doi.org\/10.1016\/B978-0-12-800267-4.00003-1","DOI":"10.1016\/B978-0-12-800267-4.00003-1"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMra031301","volume":"350","author":"HJ Burstein","year":"2004","unstructured":"Burstein HJ, Polyak K et al (2004) Ductal carcinoma in situ of the breast. N Engl J Med 350:1430\u20131441","journal-title":"N Engl J Med"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2018.1470722","volume":"18","author":"R Yamaguchi","year":"2018","unstructured":"Yamaguchi R, Perkins G (2018) Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration. Cancer Biol Ther 18:1\u201310. https:\/\/doi.org\/10.1080\/15384047.2018.1470722","journal-title":"Cancer Biol Ther"},{"issue":"6230","key":"2_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348(6230):74\u201380","journal-title":"Science"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","volume":"11","author":"KT Yeung","year":"2017","unstructured":"Yeung KT, Yang J (2017) Epithelial\u2013mesenchymal transition in tumor metastasis. Mol Oncol 11:28\u201339. https:\/\/doi.org\/10.1002\/1878-0261.12017","journal-title":"Mol Oncol"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576\u2013590. https:\/\/doi.org\/10.1016\/j.ccr.2011.09.009","journal-title":"Cancer Cell"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3892\/ijo.2016.3747","volume":"49","author":"Y Hong","year":"2016","unstructured":"Hong Y, Fang F, Zhang Q (2016) Circulating tumor cell clusters: what we know and what we expect (review). Int J Oncol 49:2206\u20132216. https:\/\/doi.org\/10.3892\/ijo.2016.3747","journal-title":"Int J Oncol"},{"issue":"7","key":"2_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson AC et al (2009) Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 69(7):3077\u20133086. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2281","journal-title":"Cancer Res"},{"issue":"1","key":"2_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5(1):3\u20139. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0297","journal-title":"Cancer Immunol Res"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi S, Macalinao D, Jin X et al (2016) Metastatic latency and immune evasion through autocrine inhibition of WNT article metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165:45\u201360. https:\/\/doi.org\/10.1016\/j.cell.2016.02.025","journal-title":"Cell"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4049\/jimmunol.1004145","volume":"187","author":"M Tabbekh","year":"2018","unstructured":"Tabbekh M, Franciszkiewicz K (2018) Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice. J Immunol 187:102\u2013109. https:\/\/doi.org\/10.4049\/jimmunol.1004145","journal-title":"J Immunol"},{"issue":"6","key":"2_CR13","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1349-7006.2007.00465.x","volume":"98","author":"R Zhou","year":"2007","unstructured":"Zhou R, He P, Ren Y et al (2007) Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice. Cancer Sci 98(6):882\u2013889. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00465.x","journal-title":"Cancer Sci"},{"issue":"6","key":"2_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ (2012) Tumor-derived granulocytes-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21(6):822\u2013835. https:\/\/doi.org\/10.1016\/j.ccr.2012.04.025","journal-title":"Cancer Cell"},{"issue":"6","key":"2_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-gupta","year":"2012","unstructured":"Pylayeva-gupta Y, Lee KE, Hajdu CH, Miller G, Bar-sagi D (2012) Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21(6):836\u2013847. https:\/\/doi.org\/10.1016\/j.ccr.2012.04.024","journal-title":"Cancer Cell"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Knolhoff BL, Meyer MA et al (2014) CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 74:5057\u20135070. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3723","journal-title":"Cancer Res"},{"issue":"12","key":"2_CR17","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26968","volume":"2","author":"DC Strachan","year":"2013","unstructured":"Strachan DC, Ruffell B, Oei Y et al (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells CSF1R inhibition delays cervical and mammary tumor growth in murine models by. Oncoimmunology 2(12):e26968. https:\/\/doi.org\/10.4161\/onci.26968","journal-title":"Oncoimmunology"},{"issue":"11","key":"2_CR18","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/MCB.00090-14","volume":"34","author":"AJ Garcia","year":"2017","unstructured":"Garcia AJ, Ruscetti M, Arenzana TL, Tran LM, Bianci-frias D, Sybert E (2017) Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor. Mol Cell Biol 34(11):2017\u20132028. https:\/\/doi.org\/10.1128\/MCB.00090-14","journal-title":"Mol Cell Biol"},{"issue":"March","key":"2_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","volume":"29","author":"G Pasello","year":"2018","unstructured":"Pasello G, Zago G, Lunardi F et al (2018) Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical\u2013pathological features and intratumor heterogeneity over time original article. Ann Oncol 29(March):1258\u20131265. https:\/\/doi.org\/10.1093\/annonc\/mdy086","journal-title":"Ann Oncol"},{"issue":"1","key":"2_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/modpathol.2011.144","volume":"25","author":"A Fassina","year":"2011","unstructured":"Fassina A, Cappellesso R, Guzzardo V et al (2011) Epithelial\u2013mesenchymal transition in malignant mesothelioma. Mod Pathol 25(1):86\u201399. https:\/\/doi.org\/10.1038\/modpathol.2011.144","journal-title":"Mod Pathol"},{"issue":"12","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"81","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak J, Sanchez-vega F, Hoadley KA et al (2018) Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov 81(12):1548\u20131565. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0804","journal-title":"Cancer Discov"},{"issue":"February","key":"2_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep22850","volume":"6","author":"R Mezzapelle","year":"2016","unstructured":"Mezzapelle R, Rrapaj E, Gatti E et al (2016) Human malignant mesothelioma is recapitulated in immunocompetent BALB\/c mice injected with murine AB cells. Sci Rep 6(February):22850. https:\/\/doi.org\/10.1038\/srep22850","journal-title":"Sci Rep"},{"issue":"15","key":"2_CR23","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","volume":"76","author":"H Schwartz","year":"2016","unstructured":"Schwartz H, Blacher E, Amer M et al (2016) Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Res 76(15):4359\u20134372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0485","journal-title":"Cancer Res"},{"issue":"12","key":"2_CR24","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26968","volume":"2","author":"DC Strachan","year":"2013","unstructured":"Strachan DC, Ruffell B, Oei Y et al (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells. Oncoimmunology 2(12):e26968. https:\/\/doi.org\/10.4161\/onci.26968","journal-title":"Oncoimmunology"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Knolhoff BL, Meyer MA et al (2014) CSF1\/CSF1R blockade reprograms tumor-in filtrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 74:5057\u20135070. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3723","journal-title":"Cancer Res"},{"issue":"February","key":"2_CR26","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3389\/fimmu.2019.00193","volume":"10","author":"H Menon","year":"1933","unstructured":"Menon H, Ramapriyan R, Cushman TR et al (1933) Role of radiation therapy in modulation of the tumor stroma and microenvironment. Front Immunol 10(February):2019. https:\/\/doi.org\/10.3389\/fimmu.2019.00193","journal-title":"Front Immunol"},{"issue":"8","key":"2_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrclinonc.2016.30","volume":"13","author":"MB Bernstein","year":"2016","unstructured":"Bernstein MB, Krishnan S, Hodge JW, Chang JY (2016) Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? Nat Rev Clin Oncol 13(8):516\u2013524. https:\/\/doi.org\/10.1038\/nrclinonc.2016.30","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/0008-5472.CAN-06-2768","volume":"67","author":"ES Yao","year":"2007","unstructured":"Yao ES, Zhang H, Chen Y et al (2007) Increased B1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 67(2):659\u2013665. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2768","journal-title":"Cancer Res"},{"issue":"279","key":"2_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4691","volume":"7","author":"S Hu-lieskovan","year":"2015","unstructured":"Hu-lieskovan S, Mok S, Moreno BH et al (2015) Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma. Sci Transl Med 7(279):279ra41","journal-title":"Sci Transl Med"},{"issue":"5","key":"2_CR30","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","volume":"19","author":"DT Frederick","year":"2013","unstructured":"Frederick DT, Piris A, Cogdill AP et al (2013) BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res 19(5):1225\u20131232. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1630","journal-title":"Clin Cancer Res"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1758835919830826","volume":"11","author":"MS Pelster","year":"2019","unstructured":"Pelster MS, Amaria RN (2019) Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials. Ther Adv Med Oncol 11:1\u201311. https:\/\/doi.org\/10.1177\/1758835919830826","journal-title":"Ther Adv Med Oncol"},{"key":"2_CR32","first-page":"25","volume":"37","author":"A Morgan","year":"1980","unstructured":"Morgan A, Holmes A (1980) Concentrations and dimensions of coated and uncoated asbestos fibres in the human lung. Br J Ind Med 37:25\u201332","journal-title":"Br J Ind Med"},{"key":"2_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02534-2016","volume":"49","author":"IS Feder","year":"2017","unstructured":"Feder IS, Tischoff I, Theile A, Schmitz I, Merget R, Tannapfel A (2017) The asbestos fibre burden in human lungs: new insights into the chrysotile debate. Eur Respir J 49:1602534. https:\/\/doi.org\/10.1183\/13993003.02534-2016","journal-title":"Eur Respir J"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1172\/JCI118246","volume":"96","author":"AM Boylan","year":"1995","unstructured":"Boylan AM, Sanan DA, Sheppard D, Broaddus VC (1995) Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin avfi5. J Cli Invest 96:1987\u20132001","journal-title":"J Cli Invest"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1165\/ajrcmb.23.3.4094","volume":"23","author":"W Liu","year":"2000","unstructured":"Liu W, Ernst JD, Broaddus VC (2000) Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol 23:371\u2013378","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"2_CR36","first-page":"7658","volume":"9","author":"G Serio","year":"2016","unstructured":"Serio G, Pagliarulo V, Marzullo A, Punzi A, Pezzuto F (2016) Case report molecular changes of malignant mesothelioma in the testis and their impact on prognosis: analyses of two cases. Int J Clin Exp Pathol 9(7):7658\u20137667","journal-title":"Int J Clin Exp Pathol"},{"issue":"September","key":"2_CR37","first-page":"1069","volume":"105","author":"JM Marsella","year":"1997","unstructured":"Marsella JM, Liu BL, Vaslet CA, Kane AB (1997) Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers. Environ Health Perspect 105(September):1069\u20131072","journal-title":"Environ Health Perspect"},{"issue":"5","key":"2_CR38","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","volume":"20","author":"A de Reynies","year":"2014","unstructured":"de Reynies A, Jaurand M-C, Renier A et al (2014) Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res 20(5):1323\u20131335. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2429","journal-title":"Clin Cancer Res"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jcp.2010.076794","volume":"63","author":"CT Chung","year":"2010","unstructured":"Chung CT, Da G, Santos C et al (2010) FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol 63:630\u2013634. https:\/\/doi.org\/10.1136\/jcp.2010.076794","journal-title":"J Clin Pathol"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/ijms19103056","volume":"19","author":"KH Sarun","year":"2018","unstructured":"Sarun KH, Lee K, Williams M et al (2018) Genomic deletion of BAP1 and CDKN2A are useful markers for quality control of malignant pleural mesothelioma (MPM) primary cultures. Int J Mol Sci 19:3056. https:\/\/doi.org\/10.3390\/ijms19103056","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2_CR41","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jtho.2016.05.020","volume":"11","author":"M Hylebos","year":"2016","unstructured":"Hylebos M, Van Camp G, Van Meerbeeck JP (2016) The genetic landscape of malignant pleural mesothelioma: results from massively parallel sequencing. J Thorac Oncol 11(10):1615\u20131626. https:\/\/doi.org\/10.1016\/j.jtho.2016.05.020","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/0008-5472.CAN-11-3091","volume":"72","author":"R Yamaguchi","year":"2012","unstructured":"Yamaguchi R, Perkins G (2012) Finding a panacea among combination cancer therapies. Cancer Res 72(1):18\u201323. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3091","journal-title":"Cancer Res"},{"issue":"2","key":"2_CR43","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.18632\/oncotarget.13174","volume":"8","author":"R Bruno","year":"2017","unstructured":"Bruno R, Al\u00ec G, Giannini R et al (2017) Malignant pleural mesothelioma and mesothelial hyperplasia: a new molecular tool for the differential diagnosis. Oncotarget 8(2):2758\u20132770","journal-title":"Oncotarget"},{"issue":"Suppl 9","key":"2_CR44","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2105-16-S9-S3","volume":"16","author":"S Parodi","year":"2015","unstructured":"Parodi S, Filiberti R, Marroni P et al (2015) Differential diagnosis of pleural mesothelioma using logic learning machine. BMC Bioinformatics 16(Suppl 9):S3","journal-title":"BMC Bioinformatics"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cyto.a.22602","volume":"87A","author":"AB Tosun","year":"2015","unstructured":"Tosun AB, Yergiyev O, Kolouri S, Silverman JF, Rohde GK (2015) Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens. Cytometry A 87A:326\u2013333. https:\/\/doi.org\/10.1002\/cyto.a.22602","journal-title":"Cytometry A"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuroimage.2017.11.006","volume":"167","author":"S Kundu","year":"2018","unstructured":"Kundu S, Kolouri S, Erickson KI, Kramer AF, Rohde GK, May CV (2018) Discovery and visualization of structural biomarkers from MRI using transport-based morphometry. Neuroimage 167:256\u2013275. arXiv:170504919v1","journal-title":"Neuroimage"},{"issue":"4","key":"2_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.21037\/tlcr.2017.05.02","volume":"6","author":"J Dozier","year":"2017","unstructured":"Dozier J, Zheng H, Adusumilli PS (2017) Immunotherapy for malignant pleural mesothelioma: current status and future directions. Trans Lung Cancer 6(4):315\u2013324. https:\/\/doi.org\/10.21037\/tlcr.2017.05.02","journal-title":"Trans Lung Cancer"},{"issue":"11","key":"2_CR48","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano MT, Zhang H (2010) Malignant pleural mesothelioma: a population-based study of survival. JTO Acquis 5(11):1841\u20131848. https:\/\/doi.org\/10.1097\/JTO.0b013e3181f1cf2b","journal-title":"JTO Acquis"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","volume":"72","author":"C Boutin","year":"1993","unstructured":"Boutin C, Xey F, Gouvemet J et\u00a0al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients part 2: prognosis and staging. Cancer 72:394\u2013404","journal-title":"Cancer"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/ijms19041041","volume":"19","author":"J Minnema-Luiting","year":"2018","unstructured":"Minnema-Luiting J, Vroman H, Aerts J, Cornelissen R (2018) Heterogeneity in immune cell content in malignant pleural mesothelioma. Int J Mol Sci 19:1041. https:\/\/doi.org\/10.3390\/ijms19041041","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2_CR51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/carcin\/bgq026","volume":"31","author":"E Varin","year":"2010","unstructured":"Varin E, Denoyelle C, Brotin E et al (2010) Downregulation of Bcl-x L and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis 31(6):984\u2013993. https:\/\/doi.org\/10.1093\/carcin\/bgq026","journal-title":"Carcinogenesis"},{"issue":"24","key":"2_CR52","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1182\/blood-2011-12-398834","volume":"119","author":"MA Debrincat","year":"2012","unstructured":"Debrincat MA, Josefsson EC, James C et al (2012) Mcl-1 and Bcl-xL coordinately regulate megakaryocyte survival. Blood 119(24):5850\u20135858. https:\/\/doi.org\/10.1182\/blood-2011-12-398834","journal-title":"Blood"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2018.10.009","volume":"195","author":"R Yamaguchi","year":"2019","unstructured":"Yamaguchi R, Lartigue L, Perkins G (2019) Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy. Pharmacol Ther 195:13\u201320","journal-title":"Pharmacol Ther"},{"issue":"November","key":"2_CR54","first-page":"3508","volume":"5","author":"Y Soini","year":"1999","unstructured":"Soini Y, Kinnula V, Kaarteenaho-wiik R, Apoptosis KE (1999) Expression of apoptosis regulating proteins bcl-2. Clin Cancer Res 5(November):3508\u20133515","journal-title":"Clin Cancer Res"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1016\/j.febslet.2015.11.009","volume":"589","author":"R Yamaguchi","year":"2015","unstructured":"Yamaguchi R, Perkins G, Hirota K (2015) Targeting cholesterol with beta-cyclodextrin sensitizes cancer cells for apoptosis. FEBS Lett 589:4097. https:\/\/doi.org\/10.1016\/j.febslet.2015.11.009","journal-title":"FEBS Lett"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-35727-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T15:14:26Z","timestamp":1609773266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-35727-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030357269","9783030357276"],"references-count":55,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-35727-6_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}